GlassScriptPhysician profile
James H Howitt
NPI 1245232669
$5,668.72
in general payments reported to CMS, 2019-2025
21 companies · $1,008 in 2025
The $1,008 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $571 · 2021: $698 · 2022: $599 · 2023: $680 · 2024: $1,197 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,885.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,670.97 | 2019-2025 | Clareon, Centurion, Unity |
| Allergan, INC. | $882.83 | 2019-2022 | |
| Abbvie INC. | $553.20 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $447.98 | 2021-2025 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $427.92 | 2019-2022 | |
| Amgen INC. | $426.18 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $304.34 | 2022-2025 | Envista Mx60 Iol, Vyzulta, Xiidra |
| Aerie Pharmaceuticals, INC. | $285.90 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $152.81 | 2019-2022 | |
| Horizon Therapeutics Plc | $138.85 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $73.38 | 2022-2024 | Acuvue |
| Thea Pharma INC. | $54.90 | 2023-2024 | Iyuzeh |
| Carl Zeiss Meditec USA, INC. | $46.53 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.09 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $37.80 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $24.82 | 2022-2025 | Clearpath, Via360, Streamline |
| Sight Sciences, INC. | $20.92 | 2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $20.00 | 2023 | Tyrvaya |
| Rxsight INC | $19.96 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $19.77 | 2021 | |
| Eyevance Pharmaceuticals LLC | $15.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Howitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.